SCHEMBL14907810

SCHEMBL14907810

COc1ccc2cc(-c3cccc(-c4nnc(SCC(=O)O)[nH]4)c3)ccc2c1

nearest known ligand 0.68

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 9/20 0.68
CYP11B1 P15538 2/20 0.44
CYP11B2 P19099 2/20 0.44
FFAR1 O14842 3/20 0.43
PIN1 Q13526 1/20 0.42
HPGD P15428 3/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PPARD Q03181 1/20 0.41
MAPT P10636 1/20 0.41
PRMT5 O14744 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
WDR77 Q9BQA1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907887 0.94 GRK6 (0.59) GRK6CYP11B1CYP11B2FFAR1HPGD
SCHEMBL14907739 0.89 GRK6 (0.63) GRK6PIN1ALDH1A1KDM4EMAPT
SCHEMBL14907787 0.88 GRK6 (0.65) GRK6ALDH1A1KMT2AKDM4E
SCHEMBL17213148 0.87 GRK6 (0.52) GRK6CYP11B1CYP11B2FFAR1HPGD
SCHEMBL21763943 0.87 GRK6 (0.52) GRK6CYP11B1CYP11B2FFAR1MAPT
SCHEMBL17213107 0.85 GRK6 (0.56) GRK6CYP11B1CYP11B2FFAR1HPGD
SCHEMBL16171184 0.84 GRK6 (0.53) GRK6PIN1HPGDALDH1A1KDM4E
SCHEMBL21763932 0.84 TDP1 (0.46) GRK6HPGDMEN1ALDH1A1KMT2A
SCHEMBL20877617 0.84 GRK6 (0.52) GRK6FFAR1HPGDMEN1ALDH1A1
SCHEMBL17214715 0.83 GRK6 (0.50) GRK6CYP11B1CYP11B2FFAR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3134390-B1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUND MEDICAL EDUCATION & RES (US) 2020-02-26 EP disclosed
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2019-04-09 US disclosed
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2017-02-23 US disclosed
WO-2015164415-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2015-10-29 WO disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2014-10-16 US disclosed
WO-2013063458-A2 INHIBITING G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050939-A1 SMALL MOLECULE INHIBITORS OF G PROTEIN COUPLED RECEPTOR 6 KINASE POLYPEPTIDES GRK6, GRK2, GRK3 GRK6 1/4885CYP11B1 3963/4885CYP11B2 3566/4885
US-20140309185-A1 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides GRK6, GRK2, GRK3 GRK6 1/4885CYP11B1 3910/4885CYP11B2 3609/4885
US-10252984-B2 Inhibiting G protein coupled receptor 6 kinase polypeptides GRK6, GRK2, GRK3 GRK6 1/4885CYP11B1 3910/4885CYP11B2 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.